Tuesday, October 17, 2017

Broken Bad, Or That's Not How Drug Czars Work

Over the weekend, both the Washington Post and CBS's 60 Minutes laid into Trump's nominee for drug czar, Rep. Tom Marino, for essentially writing a bill that made the DEA's job of tracking opioids and stopping massive shipments from drug companies impossible.

In April 2016, at the height of the deadliest drug epidemic in U.S. history, Congress effectively stripped the Drug Enforcement Administration of its most potent weapon against large drug companies suspected of spilling prescription narcotics onto the nation’s streets. 
By then, the opioid war had claimed 200,000 lives, more than three times the number of U.S. military deaths in the Vietnam War. Overdose deaths continue to rise. There is no end in sight. 
A handful of members of Congress, allied with the nation’s major drug distributors, prevailed upon the DEA and the Justice Department to agree to a more industry-friendly law, undermining efforts to stanch the flow of pain pills, according to an investigation by The Washington Post and “60 Minutes.” The DEA had opposed the effort for years. 
The law was the crowning achievement of a multifaceted campaign by the drug industry to weaken aggressive DEA enforcement efforts against drug distribution companies that were supplying corrupt doctors and pharmacists who peddled narcotics to the black market. The industry worked behind the scenes with lobbyists and key members of Congress, pouring more than a million dollars into their election campaigns
The chief advocate of the law that hobbled the DEA was Rep. Tom Marino,a Pennsylvania Republican who is now President Trump’s nominee to become the nation’s next drug czar. Marino spent years trying to move the law through Congress. It passed after Sen. Orrin G. Hatch (R-Utah) negotiated a final version with the DEA.

That was late Friday, followed with a devastating 60 Minutes piece on Sunday.  A DEA agent named Joe Rannazzisi who was fired from the DEA for criticizing Marino's bill as a deliberate effort to sink the DEA to help drug company profits blew the whistle on the department, in an interview with CBS's Bill Whitaker.

JOE RANNAZZISI: Addiction rate was still increasing. The amount of people seeking treatment was still increasing. It was all increasing. Still, the amount of prescriptions were increasing. And we started slowing down. 
As cases nearly ground to a halt at DEA, the drug industry began lobbying Congress for legislation that would destroy DEA's enforcement powers. That part of the story when we return. 
In 2013, Joe Rannazzisi and his DEA investigators were trying to crack down on big drug distributors that ship drugs to pharmacies across the country. He accused them of turning a blind eye as millions of prescription pain pills ended up on the black market. Then, a new threat surfaced on Capitol Hill. With the help of members of Congress, the drug industry began to quietly pave the way for legislation that essentially would strip the DEA of its most potent tool in fighting the spread of dangerous narcotics.

JOE RANNAZZISI: If I was gonna write a book about how to harm the United States with pharmaceuticals, the only thing I could think of that would immediately harm is to take the authority away from the investigative agency that is trying to enforce the Controlled Substances Act and the regulations implemented under the act. And that's what this bill did. 
The bill, introduced in the House by Pennsylvania Congressman Tom Marino and Congresswoman Marsha Blackburn of Tennessee, was promoted as a way to ensure that patients had access to the pain medication they needed. 
Jonathan Novak, who worked in the DEA's legal office, says what the bill really did was strip the agency of its ability to immediately freeze suspicious shipments of prescription narcotics to keep drugs off U.S. streets -- what the DEA calls diversion.

That was Sunday. So now, Marino is out as the nation's direction of drug policy today, his nomination pulled.

Rep. Tom Marino has withdrawn from consideration as the White House’s pick for drug czar following a bombshell report that he championed a bill that hindered federal agents from going after the Big Pharma firms that flooded the country with addictive opioids. 
President Donald Trump made the announcement Tuesday morning on Twitter. 
“Rep.Tom Marino has informed me that he is withdrawing his name from consideration as drug czar,” Trump wrote. “Tom is a fine man and a great Congressman!”

Sure he's great.  But when Eric Holder warned that Marino's bill would make the opioid epidemic exponentially worse?

Obama did sign the bill but there was no debate in Congress.

Besides the sponsors and co-sponsors of the bill, few lawmakers knew the true impact the law would have. It sailed through Congress without debate and was passed by unanimous consent, a parliamentary procedure reserved for bills considered to be noncontroversial. The White House was equally unaware of the bill’s import when President Barack Obama signed it into law, according to interviews with former senior administration officials.

Marino pulled a fast one...and note that his partner in crime is Marsha Blackburn, running for retiring Tennessee Senator Bob Corker's seat.  Suddenly that race got a whole lot more interesting.


No comments:

Post a Comment